| Elizabeth R Livingston, MD | |
|
222 N 2nd St, Suite 111, Boise, ID 83702-6109 | |
| (208) 381-3915 | |
| (208) 381-3918 |
| Full Name | Elizabeth R Livingston |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 35 Years |
| Location | 222 N 2nd St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083690069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M7089 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.
On the critical issues of health security and tax reform, our budget draws a clear distinction between serious reformers and those who stand in the way of the growing bipartisan consensus for principled solutions. Our budget's Medicare reforms make no changes for those in or near retirement. For those who will retire a decade from now, our plan provides guaranteed coverage options financed by a premium-support payment. And this year, our budget adds even more choices for seniors, including a traditional fee-for-service Medicare option.
Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.
An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.
Now on Kaiser Health News' blog, Phil Galewitz reports on a 'fiscal cliff' development that will impact health insurance co-ops: "The fiscal cliff deal, approved by Congress on New Year's Day, eliminates most of the more than $1.4 billion in remaining funding from the federal health law for new nonprofit, customer-owned health plans designed to compete against the major for-profit insurers."
› Verified 1 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.
On the critical issues of health security and tax reform, our budget draws a clear distinction between serious reformers and those who stand in the way of the growing bipartisan consensus for principled solutions. Our budget's Medicare reforms make no changes for those in or near retirement. For those who will retire a decade from now, our plan provides guaranteed coverage options financed by a premium-support payment. And this year, our budget adds even more choices for seniors, including a traditional fee-for-service Medicare option.
Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.
An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.
Now on Kaiser Health News' blog, Phil Galewitz reports on a 'fiscal cliff' development that will impact health insurance co-ops: "The fiscal cliff deal, approved by Congress on New Year's Day, eliminates most of the more than $1.4 billion in remaining funding from the federal health law for new nonprofit, customer-owned health plans designed to compete against the major for-profit insurers."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth R Livingston, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Elizabeth R Livingston, MD 222 N 2nd St, Suite 111, Boise, ID 83702-6109 Ph: (208) 381-3915 |
News Archive
The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.
On the critical issues of health security and tax reform, our budget draws a clear distinction between serious reformers and those who stand in the way of the growing bipartisan consensus for principled solutions. Our budget's Medicare reforms make no changes for those in or near retirement. For those who will retire a decade from now, our plan provides guaranteed coverage options financed by a premium-support payment. And this year, our budget adds even more choices for seniors, including a traditional fee-for-service Medicare option.
Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.
An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.
Now on Kaiser Health News' blog, Phil Galewitz reports on a 'fiscal cliff' development that will impact health insurance co-ops: "The fiscal cliff deal, approved by Congress on New Year's Day, eliminates most of the more than $1.4 billion in remaining funding from the federal health law for new nonprofit, customer-owned health plans designed to compete against the major for-profit insurers."
› Verified 1 days ago
Dr. Craig B. Bass, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 250 Bobwhite Ct, # 275, Boise, ID 83706 Phone: 208-333-0200 Fax: 208-333-0399 | |
Aziz George Munayirji, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 999 N Curtis Rd, Suite 415, Boise, ID 83706 Phone: 208-367-7676 Fax: 208-367-5595 | |
John M Livingston, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 8756 W Emerald St, Suite 136, Boise, ID 83704 Phone: 208-853-3051 Fax: 208-853-3053 | |
Jason A Kemp, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 N 2nd St, Suite 202, Boise, ID 83702 Phone: 208-381-6390 Fax: 208-381-6395 | |
Dr. Patrick Cole, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1070 N Curtis Rd Ste 135, Boise, ID 83706 Phone: 208-947-5390 Fax: 208-947-3465 | |
Dr. Graham W Donald, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 N 1st St Ste 280, Boise, ID 83702 Phone: 208-345-6545 Fax: 208-345-1213 | |
Courtney Alyson Green, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 999 N Curtis Rd Ste 415, Boise, ID 83706 Phone: 208-302-2600 Fax: 208-302-2625 |